Intelon Optics capabilities are unprecedented and are based on the untapped field of in-vivo Brillouin spectroscopy.
Intelon Optics is a medical device company focusing on the development and commercialization of the Brillouin Optical Scanner System (BOSS™), a technology that enables next-generation point-by-point biomechanical imaging of eye structures, extending from the cornea to the posterior part of the globe.
BOSS™ brings a wide range of novel diagnostic and surgical solutions to empower eye care professionals with high-level decision making confidence and control based on biomechanical tissue properties of the eye.
The biomechanics - or biomechanical properties - are primary and critical factors directly impacting the functionality of the eye as a refractive system. They affect functional responses of the cornea and the crystalline lens to light and greatly impact vision.
The company’s commercial focus begins with refractive surgery, and extends to other diagnostic and surgical areas in eye care. The company’s products will bring novel and unique solutions to allow deterministic surgical outcomes, control of treatment results, and a high level of decision-making confidence to clinicians and surgeons based on biomechanical tissue properties relevant to refractive error correction.
To date, BOSS™ is the only technology allowing in-vivo, localized measurement of Young’s modulus, a direct measure of the stress-strain relationship of ocular tissues influencing the refractive performance of the eye from the cornea where the light enters the eye to the retina - the sensory system.
Those solutions will eventually be offered to a broad range of customers, ranging from research institutions to health care providers in a multitude of international markets, and as OEM solutions to multi-national corporations.